Press Release

AYOXXA BIOSYSTEMS appoints Dr. Gerald Möller as Chairman of the board

Cologne 14 September 2014 - AYOXXA Biosystems GmbH, an international biotechnology company, announced that Dr. Gerald Möller has joined the company's supervisory board as an independent board director and chairman of the board. With 40 years of experience in Pharma, Diagnostics and Biotech, Dr.

Read more

Press Release

AYOXXA Biosystems wins new investors to close a € 9,0m Series B round

Cologne 7. October 2014 - AYOXXA Biosystems GmbH, an international biotechnology company, completed a € 9,0m Series B financing round by the end of June 2014. All of the company’s existing investors (High-Tech Gründerfonds, KfW, NRW.BANK, Wellington Partners Venture Capital and private investors) took part, along with new investors b-to-v Partners AG, Creathor Venture and HR Ventures.

Read more

Press Release

AYOXXA BIOSYSTEMS Extends Series B

Cologne 2 December 2014 - AYOXXA Biosystems GmbH, an international biotechnology company, announces the closing of a third round of Series B financing, bringing the total amount raised to 11.3 Mio. EUR in 2014. An additional 2.3 Mio. EUR were now invested by BioMedPartners AG, Basel and Grazia Equity GmbH, based in Stuttgart, Germany.

Read more

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

* The following fields are required for signing up our newsletter.

Connect with AYOXXA

Follow news and developments on these networks and platforms.